Ito Kazuhiko, Weinberger Kate R, Robinson Guy S, Sheffield Perry E, Lall Ramona, Mathes Robert, Ross Zev, Kinney Patrick L, Matte Thomas D
New York City Department of Health and Mental Hygiene, Bureau of Environmental Surveillance and Policy, New York, NY, 10013, USA.
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, 10032-3727, USA.
Environ Health. 2015 Aug 27;14:71. doi: 10.1186/s12940-015-0057-0.
Many types of tree pollen trigger seasonal allergic illness, but their population-level impacts on allergy and asthma morbidity are not well established, likely due to the paucity of long records of daily pollen data that allow analysis of multi-day effects. Our objective in this study was therefore to determine the impacts of individual spring tree pollen types on over-the-counter allergy medication sales and asthma emergency department (ED) visits.
Nine clinically-relevant spring tree pollen genera (elm, poplar, maple, birch, beech, ash, sycamore/London planetree, oak, and hickory) measured in Armonk, NY, were analyzed for their associations with over-the-counter allergy medication sales and daily asthma syndrome ED visits from patients' chief complaints or diagnosis codes in New York City during March 1st through June 10th, 2002-2012. Multi-day impacts of pollen on the outcomes (0-3 days and 0-7 days for the medication sales and ED visits, respectively) were estimated using a distributed lag Poisson time-series model adjusting for temporal trends, day-of-week, weather, and air pollution. For asthma syndrome ED visits, age groups were also analyzed. Year-to-year variation in the average peak dates and the 10th-to-90th percentile duration between pollen and the outcomes were also examined with Spearman's rank correlation.
Mid-spring pollen types (maple, birch, beech, ash, oak, and sycamore/London planetree) showed the strongest significant associations with both outcomes, with cumulative rate ratios up to 2.0 per 0-to-98th percentile pollen increase (e.g., 1.9 [95% CI: 1.7, 2.1] and 1.7 [95% CI: 1.5, 1.9] for the medication sales and ED visits, respectively, for ash). Lagged associations were longer for asthma syndrome ED visits than for the medication sales. Associations were strongest in children (ages 5-17; e.g., a cumulative rate ratio of 2.6 [95% CI: 2.1, 3.1] per 0-to-98th percentile increase in ash). The average peak dates and durations of some of these mid-spring pollen types were also associated with those of the outcomes.
Tree pollen peaking in mid-spring exhibit substantive impacts on allergy, and asthma exacerbations, particularly in children. Given the narrow time window of these pollen peak occurrences, public health and clinical approaches to anticipate and reduce allergy/asthma exacerbation should be developed.
多种树木花粉会引发季节性过敏性疾病,但其在人群层面上对过敏和哮喘发病率的影响尚未明确,这可能是由于缺乏长期的每日花粉数据记录,无法分析多日影响。因此,我们在本研究中的目标是确定春季个别树木花粉类型对非处方抗过敏药物销售及哮喘急诊就诊的影响。
对纽约州阿蒙克市测量的9种临床上相关的春季树木花粉属(榆树、杨树、枫树、桦树、山毛榉、白蜡树、美国梧桐/伦敦悬铃木、橡树和山核桃树)进行分析,以研究它们与2002年3月1日至2012年6月10日纽约市非处方抗过敏药物销售以及患者主要诉求或诊断代码中的每日哮喘综合征急诊就诊之间的关联。使用分布滞后泊松时间序列模型估计花粉对结果的多日影响(药物销售为0至3天,急诊就诊为0至7天),该模型对时间趋势、星期几、天气和空气污染进行了调整。对于哮喘综合征急诊就诊,还分析了年龄组。还使用斯皮尔曼等级相关性检验了花粉与结果之间平均峰值日期和第10至90百分位数持续时间的逐年变化。
春季中期的花粉类型(枫树、桦树、山毛榉、白蜡树、橡树和美国梧桐/伦敦悬铃木)与这两个结果均显示出最强的显著关联,每增加0至98百分位数的花粉,累积率比高达2.0(例如,白蜡树的药物销售和急诊就诊的累积率比分别为1.9 [95%置信区间:1.7, 2.1]和1.7 [95%置信区间:1.5, 1.9])。哮喘综合征急诊就诊的滞后关联比药物销售的滞后关联更长。关联在儿童(5至17岁)中最强(例如,白蜡树每增加0至98百分位数,累积率比为2.6 [95%置信区间:2.1, 3.1])。这些春季中期花粉类型中的一些的平均峰值日期和持续时间也与结果的平均峰值日期和持续时间相关。
在春季中期达到峰值的树木花粉对过敏和哮喘加重有实质性影响,尤其是对儿童。鉴于这些花粉峰值出现的时间窗口较窄,应制定公共卫生和临床方法来预测和减少过敏/哮喘加重。